Management of lupus nephritis has evolved considerably over the past years. Here, we
provide a comprehensive review of clinical trials that form the basis for the Kidney Disease …

The treatment of lupus nephritis has seen significant advances during the past decade
mainly due to the publication of well-designed randomized clinical trials (RCTs). The choice …

Improved understanding of lupus nephritis pathogenesis, development of novel therapies,
and optimization of clinical trial design are leading the path forward for successful drug …

The collaborative efforts of patients, clinical and translational researchers, the
pharmaceutical industry and funding sources are needed to advance therapies for lupus …

The introduction of corticosteroids and later, cyclophosphamide dramatically improved
survival in patients with proliferative lupus nephritis, and combined administration of these …

Systemic lupus erythematosus (SLE) is commonly the first autoimmune disease that comes
to mind for most people when rheumatology is mentioned. It remains an enigma that many of …

Lupus nephritis is a common and severe manifestation of systemic lupus erythematosus,
and an important cause of both acute kidney injury and end-stage renal disease. Despite its …

Despite the continuing development of immunomodulatory agents and supportive care, the
prognosis associated with lupus nephritis (LN) has not improved substantially in the past …

Despite decades of clinical research aimed at finding the most appropriate
immunosuppressive regime, lupus nephritis (LN) remains one of the major disease …

Abstract Purpose of Review Update on the diagnosis, treatment, and monitoring of lupus
nephritis. Recent Findings The recent criteria enable the earlier classification of lupus …